Kyle Mikson
Stock Analyst at Canaccord Genuity
(3.36)
# 996
Out of 5,055 analysts
106
Total ratings
45.88%
Success rate
4.97%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Maintains: Buy | $16 → $19 | $15.89 | +19.57% | 9 | Nov 7, 2025 | |
| NTRA Natera | Maintains: Buy | $200 → $250 | $204.28 | +22.38% | 10 | Nov 7, 2025 | |
| VCYT Veracyte | Maintains: Hold | $40 → $43 | $39.35 | +9.28% | 2 | Nov 5, 2025 | |
| TEM Tempus AI | Maintains: Buy | $110 → $95 | $68.48 | +38.73% | 2 | Nov 5, 2025 | |
| ILMN Illumina | Maintains: Hold | $105 → $112 | $120.67 | -7.18% | 13 | Oct 31, 2025 | |
| GH Guardant Health | Maintains: Buy | $75 → $100 | $94.37 | +5.97% | 9 | Oct 30, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $155 → $160 | $128.06 | +24.94% | 2 | Oct 29, 2025 | |
| RGEN Repligen | Maintains: Hold | $150 → $165 | $152.40 | +8.27% | 4 | Oct 29, 2025 | |
| XGN Exagen | Maintains: Buy | $11 → $15 | $9.01 | +66.48% | 5 | Oct 27, 2025 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $1 → $2 | $1.37 | +45.99% | 5 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $85 | $79.63 | +6.74% | 4 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $20 | $8.00 | +150.00% | 5 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 | $33.43 | +10.68% | 5 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $5 | $5.75 | -12.97% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.61 | +86.34% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.07 | +180.37% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $67.03 | +11.89% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.33 | +504.05% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.32 | +15,275.00% | 1 | Mar 30, 2021 |
10x Genomics
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $15.89
Upside: +19.57%
Natera
Nov 7, 2025
Maintains: Buy
Price Target: $200 → $250
Current: $204.28
Upside: +22.38%
Veracyte
Nov 5, 2025
Maintains: Hold
Price Target: $40 → $43
Current: $39.35
Upside: +9.28%
Tempus AI
Nov 5, 2025
Maintains: Buy
Price Target: $110 → $95
Current: $68.48
Upside: +38.73%
Illumina
Oct 31, 2025
Maintains: Hold
Price Target: $105 → $112
Current: $120.67
Upside: -7.18%
Guardant Health
Oct 30, 2025
Maintains: Buy
Price Target: $75 → $100
Current: $94.37
Upside: +5.97%
GeneDx Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $155 → $160
Current: $128.06
Upside: +24.94%
Repligen
Oct 29, 2025
Maintains: Hold
Price Target: $150 → $165
Current: $152.40
Upside: +8.27%
Exagen
Oct 27, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $9.01
Upside: +66.48%
Quantum-Si incorporated
Oct 27, 2025
Maintains: Hold
Price Target: $1 → $2
Current: $1.37
Upside: +45.99%
Oct 22, 2025
Maintains: Buy
Price Target: $75 → $85
Current: $79.63
Upside: +6.74%
Sep 19, 2025
Maintains: Buy
Price Target: $30 → $20
Current: $8.00
Upside: +150.00%
Sep 9, 2025
Maintains: Buy
Price Target: $37
Current: $33.43
Upside: +10.68%
Aug 11, 2025
Downgrades: Hold
Price Target: $12 → $5
Current: $5.75
Upside: -12.97%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.61
Upside: +86.34%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.07
Upside: +180.37%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $67.03
Upside: +11.89%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.33
Upside: +504.05%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.32
Upside: +15,275.00%